- Centbutidole licensed to Chemosyn Ltd. for marketing by the then Honorable Prime Minister of India (late) Shri. Rajiv Gandhi in 1986.
- Parvosine, a candidate drug for BPH licensed by Ranbaxy Laboratories Ltd. To Shwartz Germany went up to clinical trials phase-III
- CDRI 93/478 for CVS disorders and CDRI-78-103 for CNS depression (safe in toxicity evaluation)
Our mission is to establish a premier institution in the field of Pharmaceutical Education and Research to fulfill the emerging needs of the society & country to make India a world leader in pharmaceutical sciences.
Research papers : 150
( Annexure I )
Review/articles in Books/Monographs : 18
( Annexure II )
Patents (Granted/ filed) : 70 (Indian : 44 Foreign : 26)
( Annexure III )
Papers presented : 144 (National : 37 International : 107)
( Annexure IV )
Invited lectures: 142 (India: 101 Abroad: 41)
( Annexure V )
Sessions Chaired: 39
( Annexure VI )
